Inogen | INGN - Pre Tax Profit


Inogen reported $-6.06M in Pre-Tax Profit for its fiscal quarter ending in September of 2024.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
Accuray USD 3.23M 6.56M Dec/2024
AngioDynamics USD -6.4M 5.03M Sep/2025
Artivion USD 11.4M 7.84M Dec/2025
AtriCure USD 394K 1.97M Mar/2026
Baxter International USD 362M 368M Jun/2026
Becton, Dickinson and Co. USD 39M 354M Mar/2026
Boston Scientific USD 1.42B 261M Jun/2026
Cooper Companies USD 192.2M 75.4M Dec/2025
Dexcom USD 269.5M 71.2M Mar/2026
Edwards Lifesciences USD 529.3M 90.4M Jun/2026
Globus Medical USD 157.07M 12.16M Mar/2026
Inogen USD -6.06M 467K Sep/2024
Insulet USD 118.7M 5.7M Jun/2026
Medtronic USD 2.45B 1.04B Mar/2026
Orthofix International USD -2.19M 20.07M Dec/2025
Philips EUR 546M 356M Jun/2026
ResMed USD 502.31M 6.16M Mar/2026
Steris USD 304.5M 46.7M Mar/2026
Stryker USD 850M 855M Mar/2026
Tandem Diabetes Care USD -19.88M 24.56M Mar/2026
Teleflex USD -3.83M 222.77M Mar/2026
X T L Biopharmaceuticals USD -385K 168K Dec/2024
Zimmer Biomet Holdings USD 487.5M 186.2M Jun/2026